Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 28, 2014
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - July 28, 2014

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

7/28/14 - 22nd Century Group Engages CRO for FDA Regulatory Activities of Company's Modified Risk Cigarettes
By a News Reporter-Staff News Editor at Pharma Business Week 22nd Century Group, Inc. announced that it has engaged a major a contract research organization with extensive experience in tobacco exposure studies to assist the Company in certain regulatory activities at the Center for Tobacco Products of the U.S. Food and Drug Administration relate
7/28/14 - Abbott Laboratories Files SEC Form 425, Prospectuses And Communications, Business Combinations (Jul. 14, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Abbott Laboratories was posted on July 14, 2014. The SEC file number is 0001104659-14-051293.. A U.S. Securities and Exchange Commission filing is a
7/28/14 - Abbott Laboratories Files SEC Form 8-K, Current Report (Jul. 14, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Abbott Laboratories was posted on July 14, 2014. The SEC file number is 0001104659-14-051292.. A U.S. Securities and Exchange Commission filing is a
7/28/14 - Abbott Laboratories Files SEC Form 8-K, Current Report (Jul. 16, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Abbott Laboratories was posted on July 16, 2014. The SEC file number is 0001104659-14-051733.. A U.S. Securities and Exchange Commission filing is a
7/28/14 - Abbott Laboratories' Trademark Application for "ACCELERATOR A3600" Filed
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "ACCELERATOR A3600" by Michele H. Bowman, representing Abbott Laboratories. The owner/registrar information for this application is: Michele H. Bowman, Abbott
7/28/14 - Abbott Laboratories' Trademark Application for "DIABETIC PET CONNECTION" Filed
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "DIABETIC PET CONNECTION" by Elisa M. Valenzona, representing Abbott Laboratories. The owner/registrar information for this application is: Elisa M. Valenzona,
7/28/14 - Abbott Laboratories' Trademark Application for "ENSURE HEALTHY MATTERS" Filed
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "ENSURE HEALTHY MATTERS" by Anamaria E. Cashman, representing Abbott Laboratories. The owner/registrar information for this application is: Anamaria E. Cashman
7/28/14 - Abbott Laboratories' Trademark Application for "FREESTYLE PRECISION PLUS" Filed
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "FREESTYLE PRECISION PLUS" by Michele H. Bowman, representing Abbott Laboratories. The owner/registrar information for this application is: Michele H. Bowman,
7/28/14 - Abbott Laboratories' Trademark Application for "PATHWAY TO PRODUCTIVITY" Filed
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "PATHWAY TO PRODUCTIVITY" by Michele H. Bowman, representing Abbott Laboratories. The owner/registrar information for this application is: Michele H. Bowman, A
7/28/14 - Abbott Laboratories' Trademark Application for "SIX RUGGED" Filed
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "SIX RUGGED" by Michele H. Bowman, representing Abbott Laboratories. The owner/registrar information for this application is: Michele H. Bowman, Abbott Laborat
7/28/14 - Abbott Laboratories' Trademark Application for "TRONOLANE" Filed
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "TRONOLANE" by Mary L. Winburn, representing Abbott Laboratories. The owner/registrar information for this application is: Mary L. Winburn, Abbott Laboratories
7/28/14 - Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan
By a News Reporter-Staff News Editor at Pharma Business Week Abbott announced that it will sell its developed markets branded generics pharmaceuticals business to Mylan for equity ownership of a newly formed entity that will combine Mylan's existing business and Abbott's developed markets pharmaceuticals business, and will be a publicly traded...
7/28/14 - Acadia Pharmaceuticals Inc. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities (Jul. 16, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acadia Pharmaceuticals Inc. was posted on July 16, 2014. A U.S. Securities and Exchange Commission filing is a formal document or financial statement
7/28/14 - Acadia Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Jul. 16, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acadia Pharmaceuticals Inc. was posted on July 16, 2014. A U.S. Securities and Exchange Commission filing is a formal document or financial statement
7/28/14 - Acadia Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Jul. 15, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acadia Pharmaceuticals Inc. was posted on July 15, 2014. A U.S. Securities and Exchange Commission filing is a formal document or financial statement
7/28/14 - Acasti Pharma Inc. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16] (Jul. 15, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acasti Pharma Inc. was posted on July 15, 2014. The SEC file number is 0001171843-14-003275.. A U.S. Securities and Exchange Commission filing is a f
7/28/14 - Acasti Pharma Inc. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16] (Jul. 16, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acasti Pharma Inc. was posted on July 15, 2014. The SEC file number is 0001171843-14-003280.. A U.S. Securities and Exchange Commission filing is a f
7/28/14 - Acceleron Pharma Inc. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities (Jul. 16, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acceleron Pharma Inc. was posted on July 16, 2014. A U.S. Securities and Exchange Commission filing is a formal document or financial statement submi
7/28/14 - Acceleron Pharma Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Jul. 11, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acceleron Pharma Inc. was posted on July 11, 2014. A U.S. Securities and Exchange Commission filing is a formal document or financial statement submi
7/28/14 - Acceleron Pharma Inc. Files SEC Form 8-K, Current Report (Jul. 15, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acceleron Pharma Inc. was posted on July 15, 2014. A U.S. Securities and Exchange Commission filing is a formal document or financial statement submi
7/28/14 - Advaxis, Inc. Files SEC Form 8-K, Current Report (Jul. 10, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Advaxis, Inc. was posted on July 10, 2014. A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to
7/28/14 - Advaxis, Inc. Files SEC Form CT ORDER, Confidential Treatment Order (Jul. 16, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Advaxis, Inc. was posted on July 15, 2014. A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to
7/28/14 - Advaxis, Inc. Files SEC Form S-8, Securities To Be Offered To Employees in Employee Benefit Plans (Jul. 16, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Advaxis, Inc. was posted on July 16, 2014. A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to
7/28/14 - Aerie Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Jul. 11, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aerie Pharmaceuticals Inc. was posted on July 11, 2014. The SEC file number is 0001181431-14-026639.. A U.S. Securities and Exchange Commission filin
7/28/14 - Aerie Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Jul. 14, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aerie Pharmaceuticals Inc. was posted on July 14, 2014. The SEC file number is 0001193125-14-267063.. A U.S. Securities and Exchange Commission filin
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Lupus: What You Need to Know
This lesson is supported by:
RxSchool
West Virginia Best Practice Prescribing & Drug Diversion Training
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415